Referências
Principais artigos
Robertson GL. Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. Am J Med. 2006 Jul;119(7 Suppl 1):S36-42. Resumo
Gross P. Clinical management of SIADH. Ther Adv Endocrinol Metab. 2012 Apr;3(2):61-73.Texto completo Resumo
Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014 Mar;170(3):G1-47.Texto completo Resumo
Ellison DH, Berl T. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007 May 17;356(20):2064-72. Resumo
Hoorn EJ, Zietse R. Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines. J Am Soc Nephrol. 2017 May;28(5):1340-1349.Texto completo Resumo
Artigos de referência
1. Robertson GL. Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. Am J Med. 2006 Jul;119(7 Suppl 1):S36-42. Resumo
2. Gross P. Clinical management of SIADH. Ther Adv Endocrinol Metab. 2012 Apr;3(2):61-73.Texto completo Resumo
3. Feldman BJ, Rosenthal SM, Vargas GA, et al. Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med. 2005 May 5;352(18):1884-90.Texto completo Resumo
4. Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014 Mar;170(3):G1-47.Texto completo Resumo
5. Verbalis JG, Adler S, Schrier RW, et al. Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion. Eur J Endocrinol. 2011 May;164(5):725-32.Texto completo Resumo
6. Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013 Oct;126(10 suppl 1):S1-42.Texto completo Resumo
7. Liamis G, Rodenburg EM, Hofman A, et al. Electrolyte disorders in community subjects: prevalence and risk factors. Am J Med. 2013 Mar;126(3):256-63.Texto completo Resumo
8. Sherlock M, O'Sullivan E, Agha A, et al. Incidence and pathophysiology of severe hyponatraemia in neurosurgical patients. Postgrad Med J. 2009 Apr;85(1002):171-5.Texto completo Resumo
9. Zhang X, Li XY. Prevalence of hyponatremia among older inpatients in a general hospital. Eur Geriatr Med. 2020 Aug;11(4):685-692.Texto completo Resumo
10. Robertson GL. Antidiuretic hormone: normal and disordered function. Endocrinol Metab Clin North Am. 2001 Sep;30(3):671-94, vii. Resumo
11. Lien YH, Shapiro JI. Hyponatremia: clinical diagnosis and management. Am J Med. 2007 Aug;120(8):653-8. Resumo
12. Upadhyay A, Jaber BL, Madias NE. Incidence and prevalence of hyponatremia. Am J Med. 2006 Jul;119(7 Suppl 1):S30-5. Resumo
13. Miller M, Morley JE, Rubenstein LZ. Hyponatremia in a nursing home population. J Am Geriatr Soc. 1995 Dec;43(12):1410-3. Resumo
14. Ellison DH, Berl T. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007 May 17;356(20):2064-72. Resumo
15. Chung HM, Kluge R, Schrier RW, et al. Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med. 1987;83:905-908. Resumo
16. Diringer MN, Zazulia AR. Hyponatremia in neurologic patients: consequences and approaches to treatment. Neurologist. 2006;12:117-126. Resumo
17. Singh S, Bohn D, Carlotti A, et al. Cerebral salt wasting: truth, fallacies, theories, and challenges. Crit Care Med. 2002;30:2575-2579. Resumo
18. Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant. 2014 Apr;29 Suppl 2:i1-i39.Texto completo Resumo
19. Lien YH. Antidepressants and hyponatremia. Am J Med. 2018 Jan;131(1):7-8.Texto completo Resumo
20. Hoorn EJ, Zietse R. Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines. J Am Soc Nephrol. 2017 May;28(5):1340-1349.Texto completo Resumo
21. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000 May 25;342(21):1581-9. Resumo
22. Decaux G, Soupart A. Treatment of symptomatic hyponatremia. Am J Med Sci. 2003 Jul;326(1):25-30. Resumo
23. Greenberg A, Verbalis JG. Vasopressin receptor antagonists. Kidney Int. 2006 Jun;69(12):2124-30. Resumo
24. Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006 Nov 16;355(20):2099-112.Texto completo Resumo
25. Dixon MB, Lien YH. Tolvaptan and its potential in the treatment of hyponatremia. Ther Clin Risk Manag. 2008 Dec;4(6):1149-55. Resumo
26. Berl T, Quittnat-Pelletier F, Verbalis JG, et al; SALTWATER Investigators. Oral tolvaptan is safe and effective in chronic hyponatremia. J Am Soc Nephrol. 2010 Apr;21(4):705-12. Resumo
27. Cawley MJ. Hyponatremia: current treatment strategies and the role of vasopressin antagonists. Ann Pharmacother. 2007 May;41(5):840-50. Resumo
28. Nemerovski C, Hutchinson DJ. Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review. Clin Ther. 2010 Jun;32(6):1015-32. Resumo
29. Decaux G, Waterlot Y, Genette F, et al. Inappropriate secretion of antidiuretic hormone treated with frusemide. Br Med J (Clin Res Ed). 1982 Jul 10;285(6335):89-90.Texto completo Resumo
30. Kokko JP. Symptomatic hyponatremia with hypoxia is a medical emergency. Kidney Int. 2006 Apr;69(8):1291-3. Resumo
31. Refardt J, Imber C, Sailer CO, et al. A Randomized Trial of Empagliflozin to Increase Plasma Sodium Levels in Patients with the Syndrome of Inappropriate Antidiuresis. J Am Soc Nephrol. 2020 Mar;31(3):615-624.Texto completo Resumo
32. Gross P, Reimann D, Henschkowski J, et al. Treatment of severe hyponatremia: conventional and novel aspects. J Am Soc Nephrol. 2001;12(suppl 1):S10-S14.Texto completo Resumo
33. Ayus JC, Caputo D, Bazerque F, et al. Treatment of hyponatremic encephalopathy with a 3% sodium chloride protocol: a case series. Am J Kidney Dis. 2015;65:435-442.Texto completo Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal